Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis

References

• Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564–568. doi:10.1136/gutjnl-2019-318813
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577–1586. doi:10.1002/hep.28785
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723–1730. doi:10.1002/hep.28123
   PubMed Web of Science ®Google Scholar
• Xue R, Yang RX, Fan JG. Epidemiological trends and clinical characteristic of NAFLD/MAFLD in Asia. J Dig Dis. 2022;23(7):354–357. doi:10.1111/1751-2980.13117
   PubMed Web of Science ®Google Scholar
• Vitale A, Svegliati-Baroni G, Ortolani A, et al. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Gut. 2023;72(1):141–152. doi:10.1136/gutjnl-2021-324915
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi:10.1053/j.gastro.2019.11.312
   PubMed Web of Science ®Google Scholar
• Myers S, Neyroud-Caspar I, Spahr L, et al. NAFLD and MAFLD as emerging causes of HCC: a populational study. JHEP Rep. 2021;3(2):100231. doi:10.1016/j.jhepr.2021.100231
   PubMedGoogle Scholar
• Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.3055
   PubMed Web of Science ®Google Scholar
• Barazzoni R, Cederholm T, Zanetti M, Cappellari GG. Defining and diagnosing sarcopenia: is the glass now half full? Metabolism. 2023;155558. doi:10.1016/j.metabol.2023.155558
   PubMed Web of Science ®Google Scholar
• Ngo-Huang AT, Parker NH, Xiao LC, et al. Effects of a pragmatic home-based exercise program concurrent with neoadjuvant therapy on physical function of patients with pancreatic cancer: the pancfit randomized clinical trial. Ann Surg. 2023. doi:10.1097/sla.0000000000005878
   PubMed Web of Science ®Google Scholar
• Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;11(3):619–635. doi:10.1002/jcsm.12528
   PubMed Web of Science ®Google Scholar
• Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. doi:10.1016/j.metabol.2023.155533
   PubMed Web of Science ®Google Scholar
• Schmidt SF, Rohm M, Herzig S, Berriel Diaz M. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4(12):849–860. doi:10.1016/j.trecan.2018.10.001
   PubMed Web of Science ®Google Scholar
• Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5(2):e200. doi:10.1038/oncsis.2016.3
   PubMed Web of Science ®Google Scholar
• Nakamura R, Inage Y, Tobita R, et al. Sarcopenia in resected NSCLC: effect on postoperative outcomes. J Thorac Oncol. 2018;13(7):895–903. doi:10.1016/j.jtho.2018.04.035
   PubMed Web of Science ®Google Scholar
• Jogiat UM, Sasewich H, Turner SR, et al. Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: a systematic review and meta-analysis. Ann Surg. 2022;276(5):e311–e318. doi:10.1097/sla.0000000000005452
   PubMed Web of Science ®Google Scholar
• Diao YK, Liang L, Yang T. Association of sarcopenia and body composition with postoperative 90-day morbidity after liver resection for malignant tumors. JAMA Surg. 2021;156(6):590. doi:10.1001/jamasurg.2021.0231
   PubMed Web of Science ®Google Scholar
• van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(4):550–557. doi:10.1002/bjs.7823
   PubMed Web of Science ®Google Scholar
• Eslam M, El-Serag HB, Francque S, et al. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022;19(10):638–651. doi:10.1038/s41575-022-00635-5
   PubMed Web of Science ®Google Scholar
• Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23(5):625–633. doi:10.1002/lt.24750
   PubMed Web of Science ®Google Scholar
• Imai K, Takai K, Hanai T, et al. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib. Int J Mol Sci. 2015;16(5):9612–9624. doi:10.3390/ijms16059612
   PubMed Web of Science ®Google Scholar
• Yang J, Chen K, Zheng C, et al. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma. J Cachexia Sarcopenia Muscle. 2022;13(5):2383–2392. doi:10.1002/jcsm.13040
   PubMed Web of Science ®Google Scholar
• Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol. 2015;50(3):323–332. doi:10.1007/s00535-014-0964-9
   PubMed Web of Science ®Google Scholar
• Liang G, Fu W, Wang K. Analysis of t-test misuses and SPSS operations in medical research papers. Burns Trauma. 2019;7:31. doi:10.1186/s41038-019-0170-3
   PubMed Web of Science ®Google Scholar
• Reiffel JA. Propensity score matching: the “Devil is in the detail” where more may be hidden than you know. Am J Med. 2020;133(2):178–181. doi:10.1016/j.amjmed.2019.08.055
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261(6):1173–1183. doi:10.1097/SLA.0000000000000743
   PubMed Web of Science ®Google Scholar
• Yabusaki N, Fujii T, Yamada S, et al. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. Int J Surg. 2016;30:136–142. doi:10.1016/j.ijsu.2016.04.049
   PubMed Web of Science ®Google Scholar
• Wu DH, Liao CY, Wang DF, et al. Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: a multicenter analysis. Eur J Surg Oncol. 2023;49(4):802–810. doi:10.1016/j.ejso.2022.12.009
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kaido T, Hamaguchi Y, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg. 2019;269(5):924–931. doi:10.1097/SLA.0000000000002555
   PubMed Web of Science ®Google Scholar
• Chun HS, Kim MN, Lee JS, et al. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. J Cachexia Sarcopenia Muscle. 2021;12(5):1168–1178. doi:10.1002/jcsm.12754
   PubMed Web of Science ®Google Scholar
• Funk Debleds P, Chambrier C, Slim K. Postoperative nutrition in the setting of enhanced recovery programmes. Eur J Surg Oncol. 2023. doi:10.1016/j.ejso.2023.03.006
   Google Scholar
• Nachit M, Lanthier N, Rodriguez J, et al. A dynamic association between myosteatosis and liver stiffness: results from a prospective interventional study in obese patients. JHEP Rep. 2021;3(4):100323. doi:10.1016/j.jhepr.2021.100323
   PubMedGoogle Scholar